Atlantic Edge Private Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Atlantic Edge Private Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$904K	Sell	1,449 -25	-2%	-$17K	0.18%	83
2026 Q1	$1.14M	Buy	1,474 +10	+0.7%	+$7.66K	0.28%	67
2025 Q4	$1.13M	Buy	1,464 +95	+7%	+$64.5K	0.28%	67
2025 Q3	$770K	Sell	1,369 -30	-2%	-$17K	0.2%	81
2025 Q2	$734K	Sell	1,399 -304	-18%	-$170K	0.2%	83
2025 Q1	$1.08M	Hold	1,703	–	–	0.33%	69
2024 Q4	$1.21M	Buy	1,703 +20	+1%	+$16.8K	0.38%	64
2024 Q3	$1.77M	Buy	1,683 +25	+2%	+$27.8K	0.54%	47
2024 Q2	$1.74M	Buy	1,658 +33	+2%	+$32K	0.58%	44
2024 Q1	$1.56M	Buy	1,625 +88	+6%	+$83.7K	0.54%	45
2023 Q4	$1.35M	Buy	+1,537	New	+$1.27M	0.55%	46

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return

Atlantic Edge Private Wealth Management's REGN Position: Q2 2026 in Review

Atlantic Edge Private Wealth Management reduced its Regeneron Pharmaceuticals (REGN) stake by 1.7% in Q2 2026, selling an estimated $17K and leaving 1,449 shares worth $904K. The position accounts for 0.18% of the portfolio, ranked #83.

Atlantic Edge Private Wealth Management first reported a position in REGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.77M in Q3 2024. 417 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Atlantic Edge Private Wealth Management held 1,449 shares of Regeneron Pharmaceuticals worth $904K as of Q2 2026.
Atlantic Edge Private Wealth Management sold 25 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $17K.
Regeneron Pharmaceuticals made up 0.18% of Atlantic Edge Private Wealth Management's portfolio in Q2 2026, its #83 holding.
Atlantic Edge Private Wealth Management first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
Atlantic Edge Private Wealth Management's Regeneron Pharmaceuticals position peaked at $1.77M in Q3 2024.
417 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Atlantic Edge Private Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.